Marianne Davies Discusses Chemotherapy Safety for Nurses and Patients

Video

Marianne Davies, RN, MSN, ACNP, AOCN, Smilow Cancer Hospital, Yale School of Nursing, discusses the importance of chemotherapy safety.

Marianne Davies, RN, MSN, ACNP, AOCN, Smilow Cancer Hospital, Yale School of Nursing, discusses the importance of chemotherapy safety.

Davies says chemotherapy handling, administration, and education is important to both nurses and patients. At the Smilow Cancer Hospitals, nurses follow the ONS certification for safe handling of chemotherapy. Davies says her institution also added simulations to monitor how nurses are handling, double-checking, and administering chemotherapy.

Many patients are unaware of the steps that nurses take before administering chemotherapy, Davies says. Educating patients on the process is needed.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!
Recent Videos
4 experts in this video
4 experts in this video
Photo of a man wearing a suit with a blue tie in front of a dark blue background
Photo of Hope Rugo, MD
Image of a woman with blond hair in front of a dark blue background
Related Content
Photo of a main holding his lower back in pain with a graphic of a kidney overlaying

Opinion: IV Magnesium May Help Prevent Cisplatin-Induced AKI

Amanda Brink, DNP, APRN, FNP-BC, AOCNP
July 18th 2025
Article

Oncology nurses can assess patients’ risk factors and advocate for preventive strategies that protect kidney function during cisplatin therapy.

The Vitals

Seth Eisenberg Discusses New Methods of Reducing Hazardous Drug–Contaminated Toilet Aerosols in Hospital Setting

Lindsay Fischer
June 1st 2023
Podcast

Seth Eisenberg, ASN, RN, OCN, BMTCN, emphasizes the importance of reducing nurse exposure to hazardous drugs—and ongoing research efforts to improve nursing safety.

Light blue line illustration of blood cells on a dark blue background

High Tumor Volume Linked to CAR T Toxicity in LBCL

Russ Conroy
July 4th 2025
Article

Volumetric PET biomarkers may help predict risk of toxicity from CAR T-cell therapy in patients with large B-cell lymphoma, new retrospective data suggest.

The Vitals Podcast

Amber Pierce Underscores the Importance of 2-Step Verification With Relatlimab/Nivolumab

Lindsay Fischer
May 19th 2023
Podcast

Amber Pierce RN, BSN, OCN, highlights the importance of a 2-step verification process with fixed-dose regimen therapies.

Magazine page with Rx Road Map for Durvalumab for Non-Small Cell Lung Cancer

Rx Road Map: Durvalumab for Non-Small Cell Lung Cancer

Stacey Hield, BSN, RN, OCN
June 19th 2025
Article

Read Stacey Hield, BSN, RN, OCN's recommendations for the best use of durvalumab in non–small cell lung cancer.

gloves

Safety Matters When Working With Hazardous Drugs

Patricia Jakel, MN, RN, AOCN
December 25th 2023
Article

Delivering hazardous drugs safely is complex but essential for the welfare of our health care workers and our patients.